Cartagena, Junio 2007 Enrique Martinez-Barba Eduardo Calonje.
Post on 01-Apr-2015
219 Views
Preview:
Transcript
Cartagena, Junio 2007
Enrique Martinez-Barba
Eduardo Calonje
Case 1
Clinical history
• 72-yr-old man
• Axillary skin
• Pruritic hperpigmented, hyperkeratotic patches
Suggested diagnosis
• (axillary) granular parakeratosis
• No further use of deodorants, improvement within 2 weeks
Case 2Enrique Martínez-Barba
Eduardo Calonje
Clinical history
• 58-yr-old woman from Westvleteren
• Presenting with a palpable skin nodule on the right breast
• Mammography/MRI scan: ‘suspicious for malignancy’
Probably the best beer in the world!definitely
Clinical history (2)
• At the same time a CT abdomen for vague abdominal complaints was performed
• Large (6cm) mass in the small bowel mesentery, extending retroperitoneally
• ‘suspicious for lymphoma’
Clinical history (3)
• Biopsy from the skin nodule on the breast nodule
• Explorative laparascopy with biopsy of the mesenterial mass
Skin breast nodule
Mesenterial mass
S100- CD1a - CD68+
PAS +/- (a few granules) acid-fast stain (Z-N) - Oil-red-O (fat stain) +
Diagnosis?
• Clinical/radiological diagnosis: widespread malignancy (carcinoma?), dd lymphoma
• Histology: (nonspecific) fibrosis with collections of foamy macrophages, S100 and CD1a – (excluding LCH)
• Conclusion: “no diagnosis at this point”
• enters Sherlock Holmes.
“The sherlockholmian pathologist”
Review of all available biopsy material over 3 years time
• Stomach (cardia)
• Colon
• Tibia fragments
• Skin Breast nodule
• Mesenterial mass
cd68
Stomach (cardia)
colon
cd68
Tibia fragments (bilateral knee prothesis)
CD68
Diagnosis?
• “Could this be Erdheim-Chester disease (‘lipogranulosis’)?”
• Confirm by Rx legs and bone scintigraphy (bilateral metadiaphyseal sclerosis of long bones is pathognomonic of ECD)
“elementary, my dear Watson”
Erdheim-Chester disease
Bone, mesentery, retroperitoneal, breast, stomach, colon involvement
Erdheim-Chester disease
• First described in 1930 by Jacob Erdheim and William Chester• 80 cases have been reported• Histiocytic disorder with lipid-laden macrophages and
characteristic bilateral metadiaphyseal involvement of the long bones
• Differs from LCH in age distribution, macrophage characteristics (S100 and CD1a -) and type of bone involvement (osteosclerotic lesions of long bones versus osteolytic lesions of the axial skeleton)
• Etiology is unknown
Erdheim-Chester disease
• Nonosseous disease is frequent
– Hypothalamus/hypophysediabetes insipidus– Retro-orbitalexophtalmos– Retroperitonealhydronephrosis– Lunginterstitial fibrosis– Pericardialheart failure
Mild interlobular septal thickening, patchy ground glass opacities
Pericardial involvement
ECD prognosis and therapy
• Prognosis is related to the extent of the visceral involvement
• Most patients die within 2 or 3 years following diagnosis, due to congestive heart failure, lung fibrosis or renal insufficiency
• Treatment options include corticosteriods, radiotherapy, chemotherapy and immunotherapy or combination therapy. None have been highly effective and the disease is typically relentless in its course.
Jacob Erdheim William Chester
top related